Background: In reconstructive surgery, adequate perfusion of flaps is essential for successful outcomes. Assessing normal flap perfusion and differentiating it from problematic perfusion is important and time-consuming. Laser speckle contrast imaging (LSCI), an optical technique for quantitative microcirculation assessment, can be used to non-invasively monitor flap perfusion. We designed a wireless handheld LSCI device and investigated its clinical feasibility in Deep Inferior Epigastric Perforator (DIEP) flap reconstruction surgery. Methods: In a case series study with 15 patients and 20 DIEP flaps, perfusion was measured perioperatively across the 4 Hartrampf zones at 4 specific time points and on the first post-operative day. Results: In unilateral reconstructions, the perfusion in dissected flaps showed a perfusion gradient across the zones, with the highest perfusion in zone I and lowest perfusion in zone IV. The decrease in perfusion between unilateral flap elevation and temporary occlusion measurements was detected in unilateral flaps, but not in bilateral flaps. The device could detect flap failure in 2 cases by measuring anomalous perfusion values. Conclusions: The results indicate that our device is potentially valuable for flap monitoring. It detected differences in perfusion throughout the flap zones, a decrease in perfusion when clamping the pedicle and anomalous perfusion in flaps that failed. Motion artefact correction is needed to measure reliably during motion caused by patient breathing, pulse and operator motion. Further studies are needed to determine whether the wireless perfusion imager enables the early detection of complications, which could aid in prevention or prompt reintervention to salvage a flap.

Perfusion of the flap is essential in Deep Inferior Epigastric Perforator (DIEP) flap breast reconstruction surgery for flap survival, yet perioperative assessment of flap perfusion to detect perfusion-related problems is challenging. Laser Speckle Contrast Imaging (LSCI) is an optical technique for quantitative microcirculation assessment. Mounted LSCI devices are bulky and impractical to use during surgery, or in other clinical settings where investigation of microcirculation is needed. Therefore, a handheld wireless perfusion imager (WIPI) was developed including a 660 nm laser and an RGB camera for image registration. With this device, flap perfusion during surgery (at baseline, after fully raising the flap, and during ischemia) was compared for different Hartrampf zones. The results indicate that poorly perfused DIEP flap zones may be detected in an early stage using a handheld LSCI device.

Background: The use and effect of most infection control measures (ICMs) in breast implant surgery are still debated, likely resulting in undesired variation in current practices. Objectives: This study investigated the relationship between the number and combinations of ICMs used and the infection-related revision incidence after breast implant surgery. Additionally, national variation between Dutch healthcare institutions in ICM use was evaluated. Methods: For this multicentre, population-based study, all patients who received a primary breast implant or tissue expander for breast augmentation or reconstruction between 2015 and 2019 were identified from the Dutch Breast Implant Registry. Seven prospectively collected ICMs were investigated: preoperative antibiotics, implant and/or pocket irrigation, glove change, nipple guards, insertion sleeve, postoperative drains, and postoperative antibiotics. Results: This study included 52,415 implants (85% augmentation, 15% reconstruction).The median (IQR) number of ICMs used was 3 (3-4) for augmentation and 4 (4-5) for reconstruction. Median follow-up was 30 months for augmentation and 34 months for reconstruction. Infection-related revision incidence was 0.1% for augmentation and 2.1% for reconstruction. Most infection-related revisions occurred within 2 months for augmentation and 2.5 months for reconstruction. The impact of ICM use on infection-related revision incidence remained unclear, given its low incidence. A significant variation was observed between institutions in the use of postoperative antibiotics and drains. Conclusions: Although the use of different ICMs varied considerably between institutions, the infection-related revision incidence after breast implant surgery was generally low. Most surgeons used four ICMs for breast reconstruction and three ICMs for breast augmentation. Further studies on the causes and effects of the observed variation are needed.